This inventor holds 2 USPTO granted patents. Top assignee: The Radiochemical Centre Limited. Active years: 1977-1980.
Location History:
- Amersham, EN (1977)
- Amersham, GB (1980)
Company Filing History:
Years Active: 1977-1980
Title: The Innovative Contributions of John Christopher Edwards
Introduction
John Christopher Edwards is an accomplished inventor based in Amersham, GB, recognized for his significant contributions in the field of biochemistry. With two patents to his name, Edwards has dedicated his career to advancing methods of hormone assays, specifically focusing on oestrogen analysis.
Latest Patents
Edwards' latest innovations include two notable patents. The first, titled "Assay of oestrogen," outlines a method for assaying unconjugated oestriol in serum via radioimmunoassay. This method is distinct as it incorporates progesterone within the assay mixture to reduce the impact of non-specific steroid-binding proteins found in serum. The second patent, "Radio-assay of oestrogen," details a sophisticated approach for radio-assaying oestrogen in biological fluids. This method involves the competition between oestrogen and specific radio-iodine derivatives, allowing for accurate measurement of both bound and unbound fractions of oestrogen.
Career Highlights
Throughout his career, John Christopher Edwards has been associated with The Radiochemical Centre Limited, where he has contributed to various research and development projects. His work primarily focuses on improving methodologies for hormone detection, thereby enhancing the reliability of diagnostic assays in clinical settings.
Collaborations
Edwards collaborates closely with his coworker, Paul Hemesley, contributing to the innovative environment at The Radiochemical Centre Limited. Together, they work on advancing techniques that aid in the understanding and measurement of hormonal levels, which is crucial in both research and clinical diagnostics.
Conclusion
John Christopher Edwards stands out as a pivotal inventor in the field of biochemistry, particularly with his advancements in oestrogen assay methods. His patents reflect his commitment to improving diagnostic techniques, which can have far-reaching implications for public health and medical research. As he continues his work at The Radiochemical Centre Limited, his contributions are expected to pave the way for further innovations in hormone analysis.